{"id":"W2791154088","doi":"10.1038/s41375-018-0023-2","title":"Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"Celgene; Pfizer","keywords":"Ibrutinib; Mantle cell lymphoma; Temsirolimus; Medicine; Lymphoma; Open label; Internal medicine; Oncology; Phases of clinical research; Randomized controlled trial; Clinical trial; Leukemia; Chemistry; Discovery and development of mTOR inhibitors; Chronic lymphocytic leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002518486,0.0008588511,0.002332964,0.0003617252,0.0005892498,0.001305343,0.000729626,0.001208511,0.002055231],"category_scores_gemma":[0.001742803,0.0004741661,0.002723673,0.0005209253,0.0006039482,0.001299926,0.000529992,0.00207938,0.0004016724],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007816126,"about_ca_system_score_gemma":0.0006513157,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001250281,"about_ca_topic_score_gemma":0.002528333,"domain_scores_codex":[0.9990019,0.0004407626,0.00007035898,0.0001763746,0.00009603486,0.0002145947],"domain_scores_gemma":[0.9986645,0.0003504557,0.0003961805,0.0001388121,0.00006858596,0.0003814154],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7838011,0.004809486,0.1437962,0.0004256755,0.007537824,0.0003622923,0.0003112693,0.001613298,0.009100757,0.0001632424,0.002653372,0.0454254],"study_design_scores_gemma":[0.1888443,0.1250755,0.663681,0.0001405817,0.01186159,0.0007294153,0.000429976,0.002269814,0.002270618,0.0004513176,0.004116515,0.0001291249],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965066,0.00199118,0.0001075341,0.0001590528,0.00004342053,0.00006380367,0.000673857,0.000008832763,0.0004455835],"genre_scores_gemma":[0.9965916,0.0005410558,0.0001145849,0.0003448876,0.00008478732,0.00007973795,0.001744953,0.000005821617,0.0004926638],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002518486,"threshold_uncertainty_score":0.01331919,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02692729041299204,"score_gpt":0.3007514503850554,"score_spread":0.2738241599720633,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}